Fingolimod
74 interactions 5 explained in plain English
Also sold as:
Gilenya
Gilenya®
Tascenso
About Fingolimod
Fingolimod is a sphingosine-1-phosphate receptor modulator used to reduce relapses and slow disability worsening in relapsing-remitting multiple sclerosis. Read the full Fingolimod drug information page →
Medically reviewed by
Dr. Brian Staiger, PharmD, BCPS
· Updated Jun 30, 2026
· Editorial policy
· Data sources
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Contraindicated
Fingolimod Disopyramide Norpace Increased risk of QT interval prolongation, bradycardia, or heart block Details Fingolimod Dofetilide Tikosyn Increased risk of QT interval prolongation, bradycardia or heart block DetailsMajor
Fingolimod Amitriptyline Elavil Explained Increased risk of QT interval prolongation Details Fingolimod Sertraline Explained An increased risk of QT interval prolongation Details Fingolimod Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Fingolimod Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Fingolimod Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Fingolimod Arsenic Trioxide Trisenox Increased risk of QT interval prolongation Details Fingolimod Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Fingolimod Arsenic Trioxide Injection Trisenox Increased risk of QT interval prolongation Details Fingolimod Asenapine Transdermal Patch Secuado Increased risk of QT interval prolongation Details Fingolimod Atenolol Tenormin Explained Slowing of the heart rate or atrioventricular conduction, which may result in severe bradycardia or heart block Details Fingolimod Azithromycin AzaSite Increased risk of QT interval prolongation Details Fingolimod Acebutolol Sectral® Slowing of the heart rate or atrioventricular conduction, which may result in severe bradycardia or heart block Details Fingolimod Alfuzosin UroXatral Increased risk of QT interval prolongation Details Fingolimod Anagrelide Agrylin Increased risk of QT interval prolongation Details Fingolimod Bedaquiline Sirturo Increased risk of QT interval prolongation Details Fingolimod Betaxolol Betoptic S Slowing of the heart rate or atrioventricular conduction, which may result in severe bradycardia or heart block Details Fingolimod Betaxolol Ophthalmic Betoptic® Slowing of the heart rate or atrioventricular conduction, which may result in severe bradycardia or heart block Details Fingolimod Bisoprolol Zebeta® Slowing of the heart rate or atrioventricular conduction, which may result in severe bradycardia or heart block Details Fingolimod Chloroquine Aralen® Increased risk of QT interval prolongation Details Fingolimod Dasatinib Phyrago An increased risk of QT interval prolongation Details Fingolimod Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Fingolimod Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Fingolimod Digoxin Cardoxin® Severe bradycardia or heart block Details Fingolimod Dolasetron Anzemet Increased risk of QT interval prolongation Details Fingolimod Dolasetron Injection Anzemet Increased risk of QT interval prolongation Details Fingolimod Encorafenib Braftovi Increased risk of QT interval prolongation Details Fingolimod Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Fingolimod Eribulin Injection Halaven Increased risk of QT interval prolongation Details Fingolimod Esmolol Brevibloc Slowing of the heart rate or atrioventricular conduction, which may result in severe bradycardia or heart block Details Fingolimod Famotidine Calmicid Increased risk of QT interval prolongation Details Fingolimod Famotidine Injection Calmicid Increased risk of QT interval prolongation Details Fingolimod Felbamate Felbatol Increased risk of QT interval prolongation Details Fingolimod Flecainide Tambocor® Increased risk of QT interval prolongation Details Fingolimod Foscarnet Injection Foscavir Increased risk of QT interval prolongation Details Fingolimod Fostemsavir Rukobia Increased risk of torsade de pointes Details Fingolimod Galantamine Razadyne Increased risk of QT interval prolongation Details Fingolimod Gatifloxacin Ophthalmic Zymar® Increased risk of QT interval prolongation Details Fingolimod Gemifloxacin Factive Increased risk of QT interval prolongation DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacistEducational information only, not medical advice. Always confirm interactions with your pharmacist
or prescriber before making any change to your medications.